PODD

Insulet

$289.04

-3.85 (-1.31%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 11.01.2026
$375.60
(+29.95%)
Strong Buy: 5
Buy: 19
Hold: 2
Sell: 0
Strong Sell: 0
Description:
Insulet Corporation (PODD) is a pioneering leader in insulin delivery solutions, known for transforming diabetes management through its innovative Omnipod® Insulin Management System. Headquartered in Acton, Massachusetts, the company has developed a groundbreaking tubeless and wearable design that significantly enhances patient experience and flexibility for those with insulin-dependent diabetes. With a steadfast commitment to innovation and a strategic focus on expanding its global reach, Insulet is at the vanguard of the healthcare sector, aiming to elevate the standard of care for diabetes patients worldwide.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
MEDICAL DEVICES
Address:
100 NAGOG PARK, ACTON, MA, UNITED STATES, 01720
Fiscal year end:
December
Market capitalization:
$20.3 Billion
EBITDA:
$511 Million
PERatio:
84.02
EPS:
3.44
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.4

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+652%
How much will you get:
$7,518
Prices dates:
31-12-2015: $37.81 and 31-12-2025: $284.24